Strube W, Kretzdorn D, Grunmach J, Bergle R D, Thein P
Bayer AG, Geschäftsbereich Veterinär, Forschung und Entwicklung Biologie.
Tierarztl Prax. 1989;17(3):267-72.
Efficacy of the paramunity inducer Baypamun (PIND-ORF) was evaluated by an IBR challenge trial in cattle, as one model for infectious diseases in bovine. Prophylactic treatment with Baypamun protected cattle against manifestation of clinical symptoms after experimental IBR infection. The degree of protection depended on the time between paramunization and challenge infection. Even in metaphylactically paramunized cattle Baypamun reduced the IBR symptoms. In correlation to the reduction of clinical symptoms paramunization also reduced virus excretion by more than 99% in treated cattle compared to non paramunized animals. The induction of interferon following IBR infection was investigated in paramunized cattle. Application of Baypamun enabled treated animals to react faster with interferon synthesis following IBR infection than control animals did. The demonstration of the status of paramunity following Baypamun application in cattle provides a concept in the prevention of infectious disease in the practice.
作为牛传染病的一种模型,通过牛传染性鼻气管炎(IBR)攻毒试验评估了免疫增强诱导剂拜普明(PIND-ORF)的疗效。用拜普明进行预防性治疗可保护牛在实验性IBR感染后不出现临床症状。保护程度取决于免疫增强与攻毒感染之间的时间。即使是在进行群体免疫增强的牛中,拜普明也减轻了IBR症状。与临床症状的减轻相关,与未进行免疫增强的动物相比,免疫增强还使治疗后的牛的病毒排泄减少了99%以上。对免疫增强的牛感染IBR后干扰素的诱导情况进行了研究。应用拜普明使治疗后的动物在感染IBR后比对照动物能更快地产生干扰素合成反应。在牛中应用拜普明后免疫增强状态的证明为实际预防传染病提供了一个概念。